Higher Education Policy: Education Department Shifts Borrower Defense Application Reviews to Open Institutions; Will Consider Evidence from Other Regulators and Lawsuits

Caris Life Sciences: A Closer Look at Opportunities, Roadblocks for Widespread Adoption of AI-Based Precision Oncology Tools

Caris Life Sciences (CAI) earned Food and Drug Administration (FDA) approval for MI Cancer Seek, a tool that runs genetic sequencing on tumor tissue, for use as a companion diagnostic—atest that...

AT&T/EchoStar: FCC or DOJ Has Power to Kill Part of Spectrum Deal Without Seeking Court Approval—If They So Choose

The federal government has the power to kill part of AT&T’s (T) proposed $23 billion airwaves purchase from EchoStar (SATS) without going to court. The question is whether DOJ or the Federal...

GTCR/Surmodics: Private Equity Firm’s Economist Disputes FTC’s Contention That Merged Company Would Dominate Hydrophilic Coatings Market

The FTC’s estimate that GTCR’s acquisition of Surmodics (SRDX) would create a company that produces 60% of the hydrophilic coatings for medical devices in the U.S. is far too high, the private...